FDA Inspection 1207600 — Teva Czech Industries s.r.o.

Teva Czech Industries s.r.o. — FEI 1000282452

The FDA completed an inspection of Teva Czech Industries s.r.o. on September 8, 2022 in Opava. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 8, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Opava (Czech Republic)

Additional Details

Mutual Recognition Agreement (MRA)